Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Board/Management Information 2025

Feb 14, 2025

60507_rns_2025-02-14_2ed71cdc-b85c-4aa4-a0c2-c81d650c9e04.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [100 x 42] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

February 14, 2025

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation regarding completion of term of Independent Directorship of Mr. Sunil Lalbhai.

Ref.: Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby informs that Mr. Sunil Lalbhai has completed his second term as an Independent Director of the Company with effect from the end of the day on February 13, 2025.

Consequent to Mr. Lalbhai’s completion of term as an Independent Director, he ceased to be the Chairman of the Stakeholders’ Relationship Committee and Risk Management Committee and Member of the Audit Committee.

Additional details required to be disclosed pursuant to the SEBI Listing Regulations 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 , are enclosed as Annexure A.

The Company records its appreciation for the illustrious association and most valuable contributions rendered by Mr. Lalbhai during his tenure.

Please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited

PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2025.02.14 11:51:49 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

Encl.: A/a

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

Annexure A

Sr.
no
Particulars Details
1. Name Mr. Sunil Lalbhai
2. Reasons for change Completion
of
second
term
of
Independent Directorship with effect from
the end of the day on February 13, 2025.
3. Date of Cessation February 13, 2025 (EOD)
4. Affirmation as per List/Comp/14/2018-
19 dated June 20, 2018
Not Applicable
5. Relationship
inter-se Directors /
Key Managerial Personnel / Senior
Management Personnel
Not Applicable
6. Number of Shares held in the Company 2,477
7. Brief Profile Not Applicable